"
LKB1, A New Biomarker in Breast Cancer"
written by Hanine Lattouf, Coralie Poulard, Isabelle Treilleux, Nader Hussein, Mona Diab-Assaf, Muriel Le Romancer,
published by
Journal of Cancer Therapy,
Vol.7 No.10, 2016
has been cited by the following article(s):
[1]
|
Endosomal recycling inhibitors downregulate estrogen receptor-alpha and synergise with endocrine therapies
Breast Cancer Research and Treatment,
2024
DOI:10.1007/s10549-023-07225-2
|
|
|
[2]
|
LKB1: Can We Target an Hidden Target? Focus on NSCLC
Frontiers in Oncology,
2022
DOI:10.3389/fonc.2022.889826
|
|
|